about
Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience.Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk.The Effect of Body Mass Index and Weight Change on Late Gastrointestinal Toxicity in Locally Advanced Cervical Cancer Treated With Intensity-modulated RadiotherapySkeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical CancerImage-guided study of inter-fraction and intra-fraction set-up variability and margins in reverse semi-decubitus breast radiotherapyPrognostic significance of lung radiation dose in patients with esophageal cancer treated with neoadjuvant chemoradiotherapyDelineation guideline for the para-aortic lymph node region in cervical cancerImpact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodesMuscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical CancerMuscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancerPrognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancerMuscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancerLymph Node Number Predicts the Efficacy of Adjuvant Chemoradiotherapy in Node-Positive Endometrial Cancer Patients
P50
Q42009404-D8211FBA-A7BD-455B-99E7-7C151863E584Q50688723-339816D9-6E4B-42E9-A8B0-C9785B36D362Q51045247-0B9ECDA6-E9FC-4546-AF6C-687DA9ACE804Q57164246-42EF1A40-F85C-4377-87AC-1F6ABDAA2E2EQ57462237-945D54F8-AD96-4917-BDAB-9EF132E1BE81Q60932533-902FF601-10BC-449F-B7A4-158F8926663EQ64284071-BCAF1047-DAFB-432C-80E6-CF2FD8D1223EQ88884762-B9EC8C57-786F-4545-857A-218F2CCEB7FBQ89713797-BA61AC85-090F-4A46-ACBF-FBC0ADF31180Q90162543-C66F8FF0-0E77-4107-A015-13754220F026Q92062754-69A18A31-9555-4A57-87A4-790658447811Q92968154-C31A535A-871D-4E33-B22B-9EE8FFB7CAE3Q93057256-E21DC69A-B3D5-4BD4-9D12-08E5AAB22896Q96227294-61DC0C75-48D8-4357-8C43-5FEDE4706689
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1445-2393
@en
name
Jie Lee
@ast
Jie Lee
@en
Jie Lee
@es
Jie Lee
@nl
type
label
Jie Lee
@ast
Jie Lee
@en
Jie Lee
@es
Jie Lee
@nl
prefLabel
Jie Lee
@ast
Jie Lee
@en
Jie Lee
@es
Jie Lee
@nl
P106
P31
P496
0000-0003-1445-2393